Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Drafts Proposal To Improve Human Research Regulations

This article was originally published in The Gray Sheet

Executive Summary

Citing concerns over outdated regulations, HHS is recommending multi-site institutional review board reviews, updated informed-consent processes and revised risk calculations, among other changes, in a wide-reaching proposal to improve protections for human research subjects.

You may also be interested in...



FDA Drafts New Guidance On Informed Consent For Clinical Trials

If adopted, the proposal would supersede the FDA’s 1998 Guide to Informed Consent, and comes as HHS is considering changes to the so-called “Common Rule” for human subject protection.

Researchers Debate Costs Of Clinical Trial Data Sharing At IOM Gathering

The costs associated with more expansive sharing of clinical trial data for independent research would be significant, experts warned at a meeting convened by the Institute of Medicine to help inform a planned study on strategies for increasing trial data-sharing.

HHS Agenda: Regulations To Watch For In 2013

Regulations agenda includes a proposed rule to establish standardized symbols in medical device labeling, as well as plans to issue the unique device identification final rule.

Related Content

Topics

UsernamePublicRestriction

Register

ID1132679

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel